What are Mission Vision & Core Values of Novartis Company?

Novartis Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

What are the Mission, Vision, and Core Values of Novartis?

Mission and vision statements are crucial for strategic direction, guiding businesses toward sustained success. These elements define a company's purpose, shaping its identity and aligning stakeholders. Novartis, a global pharmaceutical leader, focuses on innovative medicines across various therapeutic areas.

With net sales of $13.23 billion in Q1 2025, up 11.9%, and net income surging by 34.3% to $3.61 billion, Novartis demonstrates significant market impact. Their mission, vision, and core values steer business decisions, drive scientific innovation, and contribute to improving lives globally. For further insights, consider reviewing the Novartis PESTEL Analysis.

This mission statement highlights a global focus on patients, aiming to deliver innovative medicines and breakthrough treatments worldwide. The core value proposition lies in science-based innovation to address challenging healthcare issues, making it patient-centric and innovation-focused. This aligns with the Brief History of Novartis, which shows a consistent drive for scientific advancement.

Patient Focus

The Novartis mission emphasizes improving and extending lives, directly benefiting patients globally.

Innovation Driven

Discovering new ways underscores a commitment to scientific research and development.

Global Reach

The mission implies a worldwide scope, aiming to impact health across diverse populations.

Ethical Standards

Novartis core values and ethical standards guide its pursuit of medical advancements.

Strategic Priorities

The Novartis strategic goals are aligned with its mission to transform patient lives.

Future Outlook

Novartis vision for the future focuses on continuous innovation in healthcare.

Novartis's commitment to its mission is evident in its substantial investment in research and development. In 2024, Novartis invested $5.3 billion in R&D. This included a commitment of $250 million over five years (2021-2025) specifically for neglected tropical diseases and malaria, showcasing their dedication to scientific advancement and global health equity. The FDA's accelerated approval in 2024 for Scemblix for the first-line treatment of Philadelphia chromosome-positive Chronic Myeloid Leukemia directly reflects their pursuit of new ways to improve lives through groundbreaking therapies, reinforcing the Novartis company mission statement.

Novartis SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Novartis's vision is to be the most valued and trusted medicines company globally, aiming to transform healthcare through pioneering medical advancements. This forward-looking vision is supported by strong financial performance, including a 15% increase in net sales at constant currencies in Q1 2025.

Novartis Mission

The Novartis mission is to reimagine medicine to improve and extend people's lives. This involves delivering innovative medicines and solutions.

Novartis Vision

Novartis's vision for the future is to be a trusted leader in changing the practice of medicine, becoming the most valued and trusted medicines company worldwide.

Core Values

Novartis core values include innovation, quality, collaboration, performance, courage, and integrity, guiding their ethical standards and employee behavior.

Strategic Goals

Novartis strategic goals focus on sustained growth and leadership in key therapeutic areas, supported by significant R&D investments and pipeline advancements.

Company Culture

The Novartis company culture emphasizes curiosity, unbossed leadership, and a commitment to diversity and inclusion, fostering an environment of continuous learning.

Market Position

Novartis maintains a strong market position, with Q1 2025 core operating income rising by 27%, driven by priority brands like Entresto, Kisqali, and Kesimpta.

The Novartis vision for the future is to be a trusted leader in changing the practice of medicine, aspiring to be the most valued and trusted medicines company in the world. This vision is supported by robust financial performance, with the company raising its full-year 2025 guidance to project high single-digit sales growth and low double-digit core operating income growth. For more insights into their market approach, consider reading about the Target Market of Novartis.

Novartis PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Novartis operates under six core values that define its culture and guide employee behavior. These values are integral to their recruitment, development, and performance assessment frameworks, shaping the Novartis company culture.

The four core values of Novartis are Innovation, Quality, Collaboration, and Performance. These principles drive the company's strategic goals and commitment to reimagining medicine.

Innovation - By experimenting and delivering solutions

This value manifests in Novartis's relentless pursuit of new treatments and therapies, driving significant R&D investments. For instance, the company plans to invest $23 billion over five years in US-based manufacturing and R&D, focusing on advanced therapy platforms like gene therapies and radioligand therapy advancements.

Quality - By taking pride in doing ordinary things extraordinarily well

This value is evident in Novartis's commitment to the highest standards in manufacturing and clinical trials, ensuring the safety and efficacy of its medicines. It underpins robust compliance frameworks and meticulous attention to detail in all business practices.

Collaboration - By championing high performing teams with diversity and inclusion

Novartis fosters a culture that celebrates collaboration and community, recognizing that breakthroughs require diverse perspectives. This is seen in their partnerships, such as the 30 deals signed in 2024, including the acquisition of Anthos Therapeutics in February 2025 for $3.1 billion to expand its cardiovascular pipeline, aligning with the Novartis mission vision values.

Performance - By prioritizing and making things happen with urgency

This value drives Novartis's focus on delivering strong financial and operational results. It is reflected in their ability to achieve double-digit growth in sales and net profit in 2024, and their upward revised guidance for 2025, demonstrating an urgent drive to meet strategic goals and provide value to shareholders and society, reflecting Novartis strategic priorities and values.

Beyond these, Novartis also emphasizes Courage and Integrity as core values. To understand how these principles translate into actionable strategies, explore the Growth Strategy of Novartis and how mission and vision influence the company's strategic decisions.

Novartis Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

A company's mission and vision statements are crucial for guiding its strategic decisions and shaping its overall direction. They articulate the organization's fundamental purpose and its aspirations for the future, influencing everything from product development to market positioning.

Novartis's Mission and Vision: A Strategic Compass

Novartis's mission to 'discover new ways to improve and extend people's lives' and its vision to be a trusted leader in changing the practice of medicine are the driving forces behind its strategic choices.

• Focus on four core therapeutic areas: cardiovascular-renal-metabolic, immunology, neuroscience, and oncology.
• Commitment to significant investment in research and development.
• Strategic pursuit of acquisitions to bolster pipeline and capabilities.
• Emphasis on fostering an 'inspired, curious, and unbossed' company culture.

Strategic Alignment in R&D Investment

The company's strategic decisions are directly informed by its mission. For instance, the commitment to invest $23 billion over five years in US-based manufacturing and R&D operations, aiming for domestic production of key medicines, exemplifies this alignment.

Acquisitions Fueling Future Growth

Strategic acquisitions, such as Anthos Therapeutics for $3.1 billion in February 2025 and Kate Therapeutics for $1.1 billion in November 2024, are undertaken to enhance its gene therapy and cardiovascular pipelines, directly supporting its long-term vision.

Product Development Driven by Purpose

The company's robust pipeline of over 30 potentially high-value new molecular entity (NME) candidates in clinical phases I-III is a testament to its mission-driven product development strategy.

Financial Performance Reflects Strategic Success

In Q1 2025, the company reported a 15% increase in net sales at constant currencies and a 27% increase in core operating income, demonstrating the success of its strategically aligned operations.

Culture as a Strategic Enabler

The company's core values, fostering an 'inspired, curious, and unbossed' culture, are viewed as essential for driving performance and integrating environmental, social, and governance (ESG) efforts.

Impact on Healthcare Transformation

The mission and vision statements directly influence strategic decisions, aiming to transform patient lives and change the practice of medicine, as detailed in the Mission, Vision & Core Values of Novartis article.

The mission and vision statements are integral to the company's strategic decision-making, guiding investments and operational focus to achieve its overarching goals of improving and extending lives.

Novartis Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Novartis's mission and vision statements are foundational to its operations, guiding its efforts to reimagine medicine. Enhancements could further solidify its leadership by explicitly integrating digital advancements and a broader commitment to health equity.

Integrate Digital Transformation Explicitly

To further align with industry shifts, Novartis could explicitly incorporate 'data science and digital' into its mission or vision. This would underscore its commitment to leveraging advanced analytics and AI for innovation, reflecting its strategic priority to lead in the digital health era.

Emphasize Health Equity and Access

Expanding the vision to explicitly address 'health equity and patient access' would resonate with evolving consumer expectations. This aligns with initiatives like reaching over 23 million patients by 2025 through access programs, reinforcing its strong ESG performance, evidenced by an average ESG score of 85.58 over the last five years.

Incorporate Planetary Health Commitment

Adapting mission and vision to explicitly address sustainability, beyond targets like net-zero by 2040, would demonstrate a deeper commitment to planetary health as integral to human health. This proactive stance can further differentiate the company for Owners & Shareholders of Novartis.

Strengthen Future-Oriented Language

Refining the language to be more explicitly forward-looking regarding emerging technologies and personalized medicine would better position the company. This ensures the Novartis mission vision values remain dynamic and responsive to the rapidly evolving healthcare landscape.